Skip to content
Aton
EN
FR
EN
FR
Home
About Us
Our Strategy
Our Platforms
Open menu
Our Platforms
Preclinical & Clinical Services
Monoclonal Antibodies Production
Laboratory Equipment Production
Human Tissue Provision
Insights & News
Contact Us
Investors
Newsletter Signup
Visioconference April 28, 2023
Bcell Design advances
Inoviem Scientific advances
Stemcis advances
The ANSEL family group acquires a stake
Strategic plan objectives
Videoconference November 30, 2022
Strategic plan announcement
Half-year results 2022
Agreement on sale of shares by DMS group